Skip to main content
. Author manuscript; available in PMC: 2011 Jul 11.
Published in final edited form as: Hypertension. 2006 Mar 27;47(5):887–893. doi: 10.1161/01.HYP.0000215207.54689.31

Figure 1.

Figure 1

Treatment with VEGF receptor decoy decreases the coronary vascular bed in hearts subjected to TAC. (A) TAC leads to an increase in VEGF-A transcript expression. (B) Representative images of TRITC-conjugated BS-1 lectin stained heart sections. Scale bars: 50 0 µm. (C) Quantitative analysis of capillary/myocyte ratio in Ad-cont– or Ad-Flk–treated mice at 2 weeks after sham operation or TAC. (D) Quantitative analysis of capillary density in Ad-cont– or Ad-Flk–treated mice 2 weeks after sham operation or TAC. Results are presented as mean±SEM (n=4 to 6 each). *P<0.05. #P<0.05 vs Ad-cont with sham.